Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a new build/version of the page's history metadata.
    Difference
    0.1%
    Check dated 2026-05-14T23:23:03.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The latest revision entry in the record history has been updated to v3.5.3, replacing the prior v3.5.2. This indicates the study record was updated to version v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-30T18:18:04.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    New revision entry v3.5.2 added and v3.5.0 removed from the history.
    Difference
    0.1%
    Check dated 2026-04-16T11:53:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T20:17:54.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The history shows a new revision v3.4.3 was added and v3.4.2 removed, updating the version history display.
    Difference
    0.1%
    Check dated 2026-03-11T18:17:54.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-notice banner and Revision: v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T10:30:55.000Z thumbnail image

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.